iron carbonyl 65 MG
RxNorm concept 334528, clinical drug component (scdc).
- RxCUI
- 334528
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/334528 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet (SCD, constitutes)
- ascorbic acid 125 MG / iron carbonyl 65 MG Oral Tablet (SCD, constitutes)
- ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016] (SBD, constitutes)
- iron carbonyl (IN, has ingredient)
- ascorbic acid 125 MG / iron carbonyl 65 MG [Vitron-C Reformulated Jul 2016] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 334528 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/334528 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 334528. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.